Corbin Capital Partners’s Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 HLGN.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-523,700
Closed -$19.3K 52
2023
Q3
$19.3K Hold
523,700
0.03% 36
2023
Q2
$23K Hold
523,700
0.02% 46
2023
Q1
$19.9K Hold
523,700
0.01% 60
2022
Q4
$39.3K Hold
523,700
0.01% 65
2022
Q3
$115K Buy
523,700
+23,700
+5% +$6.51K 0.03% 68
2022
Q2
$132K Hold
500,000
0.03% 70
2022
Q1
$615K Buy
500,000
+350,000
+233% +$341K 0.11% 69
2021
Q4
$255K Buy
+150,000
New +$255K 0.04% 86

Other funds holding HLGN.WS

Corbin Capital Partners's HLGN.WS Position: Q4 2023 in Review

Corbin Capital Partners sold out of Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 (HLGN.WS) in Q4 2023, closing a stake of 523,700 shares — an estimated $19.3K sold.

Corbin Capital Partners first reported a position in HLGN.WS in Q4 2021 and held it in 8 quarters. The position peaked at $615K in Q1 2022. 3 funds tracked by Wall St. Rank hold HLGN.WS as of Q4 2023.

  • Corbin Capital Partners reported no remaining Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 position as of Q4 2023 after selling out during the quarter.
  • Corbin Capital Partners sold 523,700 Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 shares in Q4 2023, an estimated $19.3K.
  • Corbin Capital Partners first reported a position in Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 in Q4 2021 and held it in 8 quarters.
  • Corbin Capital Partners's Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 position peaked at $615K in Q1 2022.
  • 3 funds tracked by Wall St. Rank held Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 as of Q4 2023.

Based on Corbin Capital Partners's 13F filing for Q4 2023, filed 15 Feb 2024.